1. Home
  2. MNKD vs DMLP Comparison

MNKD vs DMLP Comparison

Compare MNKD & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • DMLP
  • Stock Information
  • Founded
  • MNKD 1991
  • DMLP 2003
  • Country
  • MNKD United States
  • DMLP United States
  • Employees
  • MNKD N/A
  • DMLP N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • DMLP Oil & Gas Production
  • Sector
  • MNKD Health Care
  • DMLP Energy
  • Exchange
  • MNKD Nasdaq
  • DMLP Nasdaq
  • Market Cap
  • MNKD 1.1B
  • DMLP 1.3B
  • IPO Year
  • MNKD 2004
  • DMLP N/A
  • Fundamental
  • Price
  • MNKD $3.77
  • DMLP $27.66
  • Analyst Decision
  • MNKD Buy
  • DMLP
  • Analyst Count
  • MNKD 4
  • DMLP 0
  • Target Price
  • MNKD $9.75
  • DMLP N/A
  • AVG Volume (30 Days)
  • MNKD 3.3M
  • DMLP 80.2K
  • Earning Date
  • MNKD 08-06-2025
  • DMLP 07-31-2025
  • Dividend Yield
  • MNKD N/A
  • DMLP 11.65%
  • EPS Growth
  • MNKD 228.27
  • DMLP N/A
  • EPS
  • MNKD 0.10
  • DMLP 2.03
  • Revenue
  • MNKD $297,595,000.00
  • DMLP $166,824,000.00
  • Revenue This Year
  • MNKD $13.72
  • DMLP N/A
  • Revenue Next Year
  • MNKD $15.21
  • DMLP N/A
  • P/E Ratio
  • MNKD $36.30
  • DMLP $13.63
  • Revenue Growth
  • MNKD 32.50
  • DMLP 12.09
  • 52 Week Low
  • MNKD $3.51
  • DMLP $25.84
  • 52 Week High
  • MNKD $7.63
  • DMLP $34.88
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 45.09
  • DMLP 49.21
  • Support Level
  • MNKD $3.51
  • DMLP $27.50
  • Resistance Level
  • MNKD $3.83
  • DMLP $28.13
  • Average True Range (ATR)
  • MNKD 0.15
  • DMLP 0.57
  • MACD
  • MNKD 0.03
  • DMLP 0.03
  • Stochastic Oscillator
  • MNKD 53.06
  • DMLP 50.00

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.

Share on Social Networks: